Normal Cognition: Clinical Trials

6 trials for Normal Cognition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Completed 1

Follow Normal Cognition: new trials by email Literature Review of Normal Cognition trials Research Report on Normal Cognition

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK
Observational - AD - Alzheimer's Disease, Mild Cognitive Impairment
RecruitingHong Kong University of Science and Technology25002026-03-232026-07-08
Cardiovascular Risk Factors and Cognitive Trajectories
Normal Cognition, Cardiovascular Risk Factors
CompletedPeking University Sixth Hospital33722023-04-012025-03-27
CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)
Indoor Cycling (IC) - High Intensity Exercise, Normal Cognition
Not applicableActive not recruitingThe Cleveland Clinic1502021-10-202026-08-12
Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older
Ketone Ester drink, Placebo: isocaloric dextrose drink - Metabolic Syndrome, Normal Cognition
Not applicableCompletedNational Institute on Aging (NIA)992021-06-242026-04-02
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
Alzheimer Disease, Alzheimer's Disease (Incl Subtypes)
UnknownNovoic Limited402021-01-222022-04-07
Retinal Imaging in Neurodegenerative Disease
Retinal and Choroidal Imaging - Alzheimer's Disease, Mild Cognitive Impairment
RecruitingDuke University20002017-07-202026-02-04

Narrower conditions

Alzheimer Disease (4)  ·  Cognitive Dysfunction (3)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Brain Concussion (1)  ·  Brain Injuries, Traumatic (1)  ·  Dementia (1)  ·  Down Syndrome (1)  ·  Frontotemporal Dementia (1)  ·  Huntington Disease (1)  ·  Language (1)  ·  Lewy Body Disease (1)  ·  Metabolic Syndrome (1)  ·  Multiple Sclerosis (1)  ·  Parkinson Disease (1)  ·  Speech (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Mental Disorders (4)  ·  Nervous System Diseases (4)  ·  Neurocognitive Disorders (4)  ·  Neurodegenerative Diseases (4)  ·  Tauopathies (4)  ·  Cognition Disorders (3)  ·  Dementia (3)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Basal Ganglia Diseases (1)

Interventions

Watchful Waiting (1)

Sponsors

Duke University (1)  ·  Hong Kong University of Science and Technology (1)  ·  National Institute on Aging (NIA) (1)  ·  Novoic Limited (1)  ·  Peking University Sixth Hospital (1)  ·  The Cleveland Clinic (1)

Countries

United States (4)  ·  China (2)

Top investigators

Dilraj Grewal, MD (1)  ·  Dimitrios I Kapogiannis, M.D. (1)  ·  Emil Fristed, MSc (1)  ·  Jay Alberts, PhD (1)  ·  Nancy Ip, PhD (1)  ·  Sharon Fekrat, MD FACS FASRS (1)  ·  Stephen Rao, PhD (1)  ·  Xiaozhen Lv (1)

Results publications

PMID 35723922, PMID 40598011

NIH funding

R01AG070736 (1)